VistaGen Therapeutics (VTGN)
(Delayed Data from NSDQ)
$3.03 USD
-0.12 (-3.81%)
Updated Sep 23, 2024 04:00 PM ET
Pre-Market: $2.97 -0.06 (-1.98%) 8:48 AM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.40 | 1.68% |
Earnings Summary
For their last quarter, VistaGen Therapeutics (VTGN) reported earnings of -$0.35 per share, beating the Zacks Consensus Estimate of $-0.41 per share. This reflects a positive earnings surprise of 14.63%. Look out for VTGN's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.40 per share, reflecting a year-over-year increase of 39.39%.
Earnings History
Price & Consensus
Zacks News for VTGN
VistaGen Therapeutics, Inc. (VTGN) Reports Q1 Loss, Lags Revenue Estimates
VTGN: What are Zacks experts saying now?
Zacks Private Portfolio Services